Aemetis Earnings Call Transcripts
Fiscal Year 2026
-
Revenue rose 20% year-over-year to $62.7 million, with strong gains in operating income and adjusted EBITDA. Major capital projects and regulatory approvals are expected to drive further growth, while Section 45Z credits and LCFS pathway approvals remain key revenue drivers.
-
Q1 2026 saw 27% revenue growth, positive gross profit, and improved operating loss, driven by all segments. Major capital projects advanced, India biodiesel rebounded, and new LCFS pathways boosted RNG revenue. Outlook is strong with catalysts in credit markets, MVR, and India IPO.
Fiscal Year 2025
-
Q4 2025 saw improved profitability, with strong growth in dairy RNG and progress on the Keyes ethanol plant upgrade. Rising LCFS and 45Z credits, plus India expansion and IPO plans, position the business for higher cash flow in 2026.
-
Q3 2025 revenue rose to $59.2M, driven by India biodiesel and California ethanol, with improved margins and a narrowed operating loss. Dairy RNG capacity expanded, and major projects in ethanol, SAF, and carbon capture advanced. Regulatory and tax credit developments are expected to boost cash flow in Q4 and 2026.
-
Q2 2025 revenue rose to $52.2M, driven by India biodiesel and RNG growth, with net loss flat year-over-year. Regulatory changes and new tax credits are expected to boost cash flow in H2 2025 and 2026, while refinancing and an India IPO are underway to support expansion.
-
Q1 2025 saw revenues drop to $42.9M due to paused India biodiesel shipments, but a rebound is expected as shipments resume. Dairy RNG and ethanol segments are scaling, with regulatory and policy tailwinds set to drive growth, improved margins, and cash flow in the second half of 2025.
Fiscal Year 2024
-
Revenue grew 43% year-over-year to $268M in 2024, but net loss widened to $87.5M amid higher costs and regulatory delays. Major policy changes and new tax credits are expected to boost future margins, while biogas and ethanol capacity expansions continue.
-
Q3 2024 saw revenue rise to $81.4M, gross profit improve, and operating loss narrow, though a net loss was reported due to the absence of last year's one-time tax credit sale. Regulatory changes in California and federal incentives are expected to drive significant revenue growth in 2025, especially in RNG and ethanol segments.
-
Q2 2024 revenue rose 48% year-over-year to $66.6M, but net loss widened to $29.2M. Regulatory changes and operational upgrades are expected to drive over $50M in annual positive cash flow from 2025, with strong growth in biogas and India biodiesel segments.